Codivir, a medication that gets COVID-19 affected patients up and about in 48 hours with no side effects, is being developed by Code Pharma.
Zyon Ayni, Founder and CEO, said in an interview on Global Trend Monitor: “We have already found an effective way to combat HIV infected cells and started studies where we are targeting cancer cells with the same mechanism that kills HIV affected cells. The drug has been given to stage 4 cancer patients and we saw the elimination of many cancer cells. We are looking to stabilize the medication so it can reach more cancer cells”.
“For COVID-19, our team has concluded phase one with Codivir in Brazil. With that, the medication is proven to be safe, and we were able also to demonstrate a reduction in the patients’ viral load during the time course of the treatment”, Ayni concluded.
